EXECUTIVE BOARD 132nd session Provisional agenda item 10.2
EB132/21 Add.1 18 January 2013
Report on financial and administrative implications for the Secretariat of resolutions proposed for adoption by the Executive Board or Health Assembly
1. Resolution: Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination 2. Linkage to the Programme budget 2012–2013 (see document A64/7 http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_7-en.pdf) Strategic objective(s): 11 Organization-wide expected result(s): 11.1 How would this resolution contribute to the achievement of the Organization-wide expected result(s)? Access to essential medicines and medical technologies is a fundamental pillar of national health policies. Research and development of new medicines and technologies for effectively tackling the diseases that disproportionally affect developing countries is critical to improving access. It is also very important that new technologies, when developed, are affordable. Currently, spending on research and development is insufficient, and even when new medicines are developed they are not affordable. After discussions and consultations among Member States on the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination, this resolution will implement further steps aimed at enhancing sustainable funding for research and development and ensuring that the resulting products and technologies are accessible. Does the programme budget already include the products or services requested in this resolution? (Yes/no) No. 3. Estimated cost and staffing implications in relation to the Programme budget (a) Total cost Indicate (i) the lifespan of the resolution during which the Secretariat’s activities would be required for implementation and (ii) the cost of those activities (estimated to the nearest US$ 10 000). (i) three years (covering the period June 2013–May 2016) (ii) Total US$ 10.7 million (staff: US$ 2.7 million; activities: US$ 8 million). This amount does not include the total cost of one activity that will require two additional years to be fully implemented (with an additional cost of US$ 4 million for staff and activities). (b) Cost for the biennium 2012–2013 Indicate how much of the cost indicated in 3 (a) is for the biennium 2012–2013 (estimated to the nearest US$ 10 000). Total US$ 1.47 million (staff: US$ 270 000; activities: US$ 1.2 million).
EB132/21 Add.1
Indicate at which levels of the Organization the costs would be incurred, identifying specific regions where relevant. Headquarters and regional offices. Is the estimated cost fully included within the approved Programme budget 2012–2013? (Yes/no) No. If “no”, indicate how much is not included. US$ 1.47 million. (c) Staffing implications Could the resolution be implemented by existing staff? (Yes/no) No. If “no” indicate how many additional staff – full-time equivalents – would be required, identifying specific regions and noting the necessary skills profile(s), where relevant. Headquarters level: one staff member at grade P.5 and two staff members at grade P.4.
4. Funding Is the estimated cost for the biennium 2012–2013 indicated in 3 (b) fully funded? (Yes/no) No. If “no”, indicate the funding gap and how the funds would be mobilized (provide details of expected source(s) of funds). US$ 1.47 million; source(s) of funds: to be identified.
=
=
=
2